These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28085151)

  • 1. The BCL-2 pro-survival protein A1 is dispensable for T cell homeostasis on viral infection.
    Tuzlak S; Schenk RL; Vasanthakumar A; Preston SP; Haschka MD; Zotos D; Kallies A; Strasser A; Villunger A; Herold MJ
    Cell Death Differ; 2017 Mar; 24(3):523-533. PubMed ID: 28085151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of mice lacking all functional isoforms of the pro-survival BCL-2 family member A1 reveals minor defects in the haematopoietic compartment.
    Schenk RL; Tuzlak S; Carrington EM; Zhan Y; Heinzel S; Teh CE; Gray DH; Tai L; Lew AM; Villunger A; Strasser A; Herold MJ
    Cell Death Differ; 2017 Mar; 24(3):534-545. PubMed ID: 28085150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.
    Zhou S; Ou R; Huang L; Moskophidis D
    J Virol; 2002 Jan; 76(2):829-40. PubMed ID: 11752172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Bcl-2 family member A1 is developmentally regulated in T cells.
    Tomayko MM; Punt JA; Bolcavage JM; Levy SL; Allman DM; Cancro MP
    Int Immunol; 1999 Nov; 11(11):1753-61. PubMed ID: 10545479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RasGRP1 transmits prodifferentiation TCR signaling that is crucial for CD4 T cell development.
    Priatel JJ; Chen X; Dhanji S; Abraham N; Teh HS
    J Immunol; 2006 Aug; 177(3):1470-80. PubMed ID: 16849453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A1/Bfl-1 expression is restricted to TCR engagement in T lymphocytes.
    Verschelde C; Walzer T; Galia P; Biémont MC; Quemeneur L; Revillard JP; Marvel J; Bonnefoy-Berard N
    Cell Death Differ; 2003 Sep; 10(9):1059-67. PubMed ID: 12934080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses.
    Shorter SK; Schnell FJ; McMaster SR; Pinelli DF; Andargachew R; Evavold BD
    PLoS One; 2016; 11(2):e0149582. PubMed ID: 26915099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonimmunosuppressive chemotherapy: EM011-treated mice mount normal T-cell responses to an acute lymphocytic choriomeningitis virus infection.
    Aneja R; Kalia V; Ahmed R; Joshi HC
    Mol Cancer Ther; 2007 Nov; 6(11):2891-9. PubMed ID: 18025274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival but impaired homeostatic proliferation of Naïve T cells in the absence of p56lck.
    Seddon B; Legname G; Tomlinson P; Zamoyska R
    Science; 2000 Oct; 290(5489):127-31. PubMed ID: 11021796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR-dependent B-cell survival.
    Sochalska M; Ottina E; Tuzlak S; Herzog S; Herold M; Villunger A
    Cell Death Differ; 2016 Apr; 23(4):628-39. PubMed ID: 26450454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
    Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
    Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo.
    Carrington EM; Zhan Y; Brady JL; Zhang JG; Sutherland RM; Anstee NS; Schenk RL; Vikstrom IB; Delconte RB; Segal D; Huntington ND; Bouillet P; Tarlinton DM; Huang DC; Strasser A; Cory S; Herold MJ; Lew AM
    Cell Death Differ; 2017 May; 24(5):878-888. PubMed ID: 28362427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablation of CD8 and CD4 T cell responses by high viral loads.
    Fuller MJ; Zajac AJ
    J Immunol; 2003 Jan; 170(1):477-86. PubMed ID: 12496434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverging role for coronin 1 in antiviral CD4+ and CD8+ T cell responses.
    Tchang VS; Mekker A; Siegmund K; Karrer U; Pieters J
    Mol Immunol; 2013 Dec; 56(4):683-92. PubMed ID: 23933558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus.
    Thomsen AR; Nansen A; Christensen JP; Andreasen SO; Marker O
    J Immunol; 1998 Nov; 161(9):4583-90. PubMed ID: 9794385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
    Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.
    Matloubian M; Concepcion RJ; Ahmed R
    J Virol; 1994 Dec; 68(12):8056-63. PubMed ID: 7966595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells.
    Grayson JM; Zajac AJ; Altman JD; Ahmed R
    J Immunol; 2000 Apr; 164(8):3950-4. PubMed ID: 10754284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity.
    Nakajima H; Leonard WJ
    J Immunol; 1999 Jan; 162(2):782-90. PubMed ID: 9916699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.